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Background: Reuse of cardiac implantable electronic devices (CIEDs) may help address the unmet need
among patients in low- and middle-income countries (LMICs).
Methods:To examineHeart RhythmSociety (HRS) physicians’ opinions regarding CIED reuse, an online
survey eliciting attitudes toward CIED reuse was sent to all 3,380 HRS physician members.
Results: There were 429 responses (response rate 13%). A large majority of respondents agreed or
strongly agreed that resterilization of devices for reimplantation in patients who cannot afford new devices
may be safe (370, 87%) and, if proven to be safe, would be ethical (375, 88%). A total of 340 (81%)
respondents would be comfortable asking their patients to consider donating their device, and 353 (84%)
would be willing to reimplant a resterilized device if it were legal. The most commonly cited concerns
about device reuse were infection (270, 64%) and device malfunction (125, 29%). Respondents from
the United States and Canada had more favorable impressions of device reuse than respondents from
other high-income countries (P < 0.05 for three of five positive statements regarding reuse), and were less
likely to cite ethical concerns (P < 0.001). However, when responses from all high-income countries were
compared with lower- and upper-middle income countries, there were no significant differences in the
rates of approval.
Conclusions: HRS survey respondents support the concept of CIED reuse for patients in LMICs who
cannot afford new devices. Studies are needed to demonstrate the clinical efficacy and safety of this
practice and to identify potential barriers to adoption among physicians. (PACE 2014; 37:969–977)
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Introduction
Pacemakers and implantable cardioverter
defibrillators (ICDs) have revolutionized the treat-
ment of bradyarrythmias and tachyarrythmias in
wealthy countries, but unfortunately they remain
unaffordable for many patients in low- and
middle-income countries (LMICs).1 The reuse of
pacemakers and ICDs, which involves harvesting
devices from deceased patients, device selection
and sterilization, and implantation in recipient
patients, may help those with no access to this
therapy in underserved nations. Numerous small
Disclosures: My Heart—Your Heart initiative is supported
by grants from the Hewlett Foundation, the Mardigian
Foundation, the University ofMichigan Cardiovascular Center,
and gifts from Mr. and Mrs. Sheldon Davis and Mr. and Mrs.
Craig Sincock. There are no conflicts of interest.
Address for reprints: Thomas C. Crawford, M.D., 1500 East
Medical Center Drive SPC 5853, Ann Arbor, MI 48109-5853.
Fax: 734-936-7026; e-mail: thomcraw@med.umich.edu
Received December 8, 2013; revised March 5, 2014; accepted
March 18, 2014.
doi: 10.1111/pace.12418
studies in a variety of settings worldwide have
demonstrated the feasibility, efficacy, and safety
of pacemaker and ICD reuse (Appendix S1 in the
Supporting information).
A successful large-scale device reuse program
would necessitate the coordinated participation
of many stakeholders. As the majority of devices
available for reuse are harvested from deceased
patients, potential donor patients and their
families, funeral home and crematory directors,
as well as physicians and allied health pro-
fessionals, all have a role to play. Project My
Heart—Your Heart is a collaboration between the
University of Michigan Cardiovascular Center,
WorldMedical Relief, theMichigan Funeral Home
Director Association, Implant Recycling, Inc.,
and numerous funeral homes and crematories
throughout the United States. Project My Heart—
Your Heart seeks to facilitate pacemaker reuse in
order to benefit individuals in LMICs.2 Previously
published survey data indicate that 89% of funeral
directors, 87% of patients with implantable
devices, and 71% of the general population
would support a pacemaker reutilization initiative
if given the opportunity.3 However, little is
©2014 Wiley Periodicals, Inc.
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currently known about Heart Rhythm Society
(HRS) physician members’ opinions regarding
device reuse. Physician acceptance is essential
to the success of a device reutilization program,
including those in donor countries (to facilitate
device explantation, screening for reusability, and
sterilization) aswell as those in recipient countries
(to select appropriate recipient patients and
perform reimplantation). In this study, we aimed
to quantitatively evaluate the attitudes of HRS
physician members toward cardiac implantable
electronic device (CIED) reuse, and to identify
potential barriers to adoption.
Methods
Survey
We developed an online survey to elicit
attitudes toward CIED reuse. The survey instru-
ment was approved byMembership and Executive
committees of the HRS and sent electronically
using SurveyMonkey (SurveyMonkey, Palo Alto,
CA, USA) to each of the 3,380 physician
members of the HRS. The survey consisted of
29 questions (Appendix S2 in the Supporting
information). Demographic questions included
physician specialty, the type of practice institution
(university/academic vs private practice, etc.),
practice setting (urban vs suburban vs rural), prac-
tice country, and country of birth. Respondents
were asked to rate their level of agreement with
various positive statements regarding device reuse
using a Likert scale (1 = strongly disagree, 2 =
disagree, 3 = neutral, 4 = agree, and 5 = strongly
agree). Respondents were also asked to identify, in
multiple-choice format, their greatest concern(s)
regarding device reuse.
Data Analysis
To simplify the analysis, responses of “dis-
agree” and “strongly disagree” were tabulated
and analyzed together, and responses of “agree”
and “strongly agree” were tabulated and analyzed
together.
In addition to seeking the attitudes of survey
respondents in aggregate, we also hypothesized
that respondents from poorer countries would
have more positive views regarding CIED reuse
than those from wealthier countries, and that
respondents from the United States and Canada
may have different views from those in other high-
income countries. Respondents were therefore
grouped into one of three categories based on
their country of practice: (1) the United States
and Canada, (2) high-income countries excluding
the United States and Canada, and (3) lower-
and upper-middle income countries. High-income
countries were defined as those designated by the
World Bank as having “high-income economies”
(per capita income of $12,616 USD or greater)—
this group included respondents from Australia,
Austria, Belgium, Finland, Germany, Greece,
Ireland, Israel, Italy, Japan, South Korea, Monaco,
Netherlands, New Zealand, Poland, Saudi Arabia,
Singapore, Spain, Sweden, United Arab Emirates,
and the United Kingdom. Lower- and upper-
middle income countries were similarly defined
as those designated by the World Bank as
having “lower-middle income economies” (per
capita income of $1,036 to $4,085 USD) or
“upper-middle income economies” (per capita
income of $4,086 to $12,615 USD)—this group
included respondents from Argentina, Belize,
Brazil, China, Colombia, India, Iran, Malaysia,
Mexico, Pakistan, Peru, Philippines, Romania, Sri
Lanka, and Taiwan.4 There were no respondents
from World Bank “low-income” countries (per
capita income of $1,035 USD or less). Using
the χ2 test, responses were compared across
the three income economy groups represented
(i.e., United States and Canada vs other high-
income countries vs lower- and upper-middle
income countries). A simpler two-group analysis
was also performed that compared responses
from all high-income countries (United States,
Canada, and others) against those from lower- and
upper-middle income countries. Analyses were
performed using SPSS for Windows (IBM Corp.,
Armonk, NY, USA).
Results
Respondent Characteristics and General
Perceptions
There were 429 responses (response rate
13%). The characteristics of the respondents
are shown in Table I. The majority were elec-
trophysiologists (N = 389, 91%), followed by
general cardiologists (N = 15, 3.5%) and pediatric
cardiologists (N = 8, 1.9%). Two hundred sixteen
(50%) operated at a university or academic
medical center and about one quarter worked
in private medical practice (N = 115, 27%).
The respondents’ practice settings were primarily
urban (N = 301, 70%). The majority (N = 298,
70%) of respondents practiced in the United
States, although only 210 (50.1%) had been born
in the United States. Thirty-nine respondents
(9.2%) were from lower- or upper-middle income
countries.
Three hundred ninety-nine (93%) respon-
dents had implanted a cardiac device in the
preceding 12 months, with 353 (82%) reporting
implanting greater than 25 pacemakers per year,
and 309 (72%) reporting implanting greater than
25 ICDs or biventricular ICDs. Three hundred fifty-
six (84%) respondents reported following at least
100 patients in their practice.
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Table I.
Demographic Characteristics of Survey Respondents
Demographic Variable N (% of Respondents)
Specialty
Electrophysiologist 389 (90.7%)
General cardiologist 15 (3.5%)
Pediatric cardiologist 8 (1.9%)
Interventional cardiologist 4 (0.9%)
Cardiovascular surgeon 4 (0.9%)
Other 7 (1.7%)
Practice institution
University/academic center 216 (50.3%)
Private medical practice 115 (26.8%)
Employed position with a
nonacademic medical
practice
64 (14.9%)
Public/government
sponsored medical center
24 (5.6%)
Other 8 (1.9%)
Practice setting
Urban 301 (70.2%)
Suburban 100 (23.3%)
Rural 21 (4.9%)
Practice country
United States 298 (70.1%)
Canada 18 (4.2%)
Japan 14 (3.3%)
United Kingdom 11 (2.6%)
Australia 9 (2.1%)
Brazil 9 (2.1%)
Netherlands 6 (1.4%)
India 5 (1.2%)
Mexico 5 (1.2%)
Other 50 (12%)
Country income group by
place of practice†
United States or Canada 316 (74.4%)
High-income country
outside of the United
States and Canada
70 (16.5%)
Lower- or upper-middle
income country
39 (9.2%)
†
“High-income” countries are defined as those having per capita
income of $12,616 USD or greater; “upper-middle income”
countries are defined as those having per capita income from
$4,086 to $12,615 USD; “lower-middle income” countries are
defined as those having per capita income from $1,036 to $4,085
USD (World Bank classifications). There were no respondents in
this sample from “low-income” countries (per capita income of
$1,035 USD or less). N = 429. Some columns may contain fewer
total responses due to incomplete responses.
One hundred two (23.8%) of those surveyed
indicated that in the country where they practice,
there were patients who did not receive pacemak-
ers or ICDs due to inability to afford them. Forty-
four (10%) respondents indicated that they were
aware of some patients who, due to an inability to
afford a new one, had received a resterilized CIED.
Sixty (28.4%) of those surveyed said they would
be interested in receiving postmortem pacemakers
or ICDs for use in their patients; 41 (9.6%) had
personally implanted a resterilized pacemaker
or ICD, of whom 17 (41.5%) practice in lower-
and upper-middle income countries. Forty-five
respondents reported having received donation of
brand new CIEDs from Heartbeat International,
Inc. (6), other charitable sources (7), or directly
from the device manufacturers (32). One hundred
forty-one respondents (33.1%) reported having
been asked by their patients or patients’ family
members about the possibility of donating their
CIED in the event of death. Two hundred fifty-
five (60.1%) indicated they would be interested
in receiving more information about postmortem
reuse of pacemakers and ICDs. Of those respon-
dents asked about the greatest obstacles for their
patients to undergo CIED implantation (whether
of a new or reused device), 121 (56.5%) reported
cost, 15 (7.0%)–access to implanting facilities, 15
(7.0%)–access to implanting physicians, and 47
(22.0%)–other (answers not mutually exclusive;
Table II). Respondents from lower- and upper-
middle income countries were nearly twice as
likely to cite cost than other respondents (90.3%
vs 50.8%, P < 0.001).
Opinions Regarding CIED Reuse
HRS members’ level of agreement with
various statements about CIED reuse is shown
in Figure 1 and Table III. The opinions of both
donation and reuse were overall very positive,
with the level of agreement (i.e., “strongly agree”
or “agree”) ranging from 81% (N = 340; “I
would be comfortable asking my patients with
an implanted pacemaker or ICD to consider
donating their devices to a reutilization program
upon their death”) to 88% (N = 375; “I believe
resterilization of pacemakers or ICDs with >70%
of the original battery life reclaimed fromdeceased
patients in order to reimplant them in patients
who cannot afford a new pacemaker is ethical,
if it is proven to be safe”). Three hundred fifty-
three (84%) respondents agreedwith the statement
“If allowed by the law, I would be willing to
implant postmortem pacemakers or ICDs that
were resterilized and contained >70% of original
battery life in a patient who is unable to obtain
a new device.” When asked: “In the country
PACE, Vol. 37 August 2014 971
HUGHEY, ET AL.
Table II.
HRS Members’ Perceived Barriers to Patients Obtaining Pacemakers and ICDs
United High-Income Lower- and
States Countries Outside Upper-Middle
or of United States Income All HRS
Canada and Canada Countries Members
N (% of N (% of N (% of N (% of
Barrier† Respondents) Respondents) Respondents) Respondents) P
Cost 89 (56.0%) 4 (16.7%) 28 (90.3%) 121 (56.5%) <0.001
Lack of access to an
implanting facility
8 (5.0%) 3 (12.5%) 4 (12.9%) 15 (7.0%) 0.160
Lack of access to an
implanting physician
11 (6.9%) 2 (8.3%) 2 (6.5%) 15 (7.0%) 0.961
Other 30 (18.9%) 11 (45.8%) 6 (19.4%) 47 (22.0%) 0.012
None 30 (18.9%) 6 (25.0%) 0 (0%) 36 (16.8%) 0.019
†Respondents were asked, “What are the greatest barriers your patients face in obtaining pacemakers or ICDs? Mark all that apply.”
Answers are not mutually exclusive. N = 214. HRS = Heart Rhythm Society.
Figure 1. HRS members’ agreement with specific statements regarding CIED reuse. Responses are presented as
percentages of respondents (N = 429). CIEDs = cardiac implantable electronic devices; HRS = Heart Rhythm Society.
where I practice, most individuals needing device
implantation, but who are unable to afford a new
device, would be willing to undergo implantation
of a device reclaimed and resterilized from a
deceased person,” there were 65 (31%) “agree”
or “strongly agree” responses, 94 (45%) “neutral”
responses, and 52 (24%) “disagree” or “strongly
disagree” responses.
The most commonly cited concern regarding
device reuse was infection (cited by 270 respon-
dents; 64%), followed by device malfunction (N
= 125, 29%), ethical concerns (N = 63, 15%),
“other,” (N = 49, 12%), and religious concerns
(N = 15, 3.5%; answers not mutually exclusive).
Ninety-two (22%) respondents had no concerns
(Table IV).
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Table IV.
HRS Members’ Concerns Related to Device Reuse by Country of Practice
United High-Income Lower- and
States Countries Outside Upper-Middle
or of United States Income All HRS
Canada and Canada Countries Members
N (% of N (% of N (% of N (% of
Concern† Respondents) Respondents) Respondents) Respondents) P
Infection 200 (63.3%) 44 (62.9%) 26 (66.7%) 270 (63.5%) 0.911
Device malfunction 89 (28.2%) 24 (34.3%) 12 (30.8%) 125 (29.4%) 0.585
Ethical 33 (10.4%) 21 (30.0%) 9 (23.1%) 63 (14.8%) <0.001
Other 35 (11.1%) 10 (14.3%) 4 (10.3%) 49 (11.5%) 0.724
Religious 11 (3.5%) 4 (5.7%) 0 (0%) 15 (3.5%) 0.300
None 73 (23.1%) 12 (17.1%) 7 (17.9%) 92 (21.6%) 0.462
†Respondents were asked, “What are your greatest concerns regarding the reutilization of postmortem pacemakers or ICDs? Please
mark all that apply.” Answers are not mutually exclusive. N = 425; country of practice data was missing for four of 429 respondents.
HRS = Heart Rhythm Society.
Attitudes toward CIED Reuse Across Country
Income Groups
The response rates were similar among
physicians from the United States or Canada
(10%), high-income countries outside of the
United States or Canada (13%), and upper- or
lower-middle income countries (13%). In general,
respondents from the United States or Canada
were more likely to agree with positive statements
about device reuse than respondents from other
high-income countries and respondents from
lower- and middle-income countries (Table III).
However, when responses from the United
States, Canada, and other high-income countries
were grouped together and compared against
those from lower- and upper-middle income
countries, there were no statistically significant
differences.
There were no significant differences between
respondents from the United States/Canada, other
high-income countries, and lower- and upper-
middle income countries in terms of naming
their main concern regarding CIED reuse (infec-
tion, device malfunction, other, religious, and
none); however, respondents from the United
States/Canada were less likely to cite ethical
concerns than the other two groups (10% vs 30%
vs 23%, P < 0.001, see Table IV).
To determine the impact of physician immi-
gration on the opinions of reuse, subgroup analysis
was performed excluding responses from physi-
cians who stated that they grew up in a different
country than the one in which they currently
practice (i.e., immigrants). Rates of agreementwith
each of the five positive statements regarding
CIED reuse were directionally similar to the
responses observed in the entire-group analysis
that also included immigrant responses (United
States/Canada—91.2% vs high-income countries
outside of United States/Canada—63.5% vs lower-
and upper-middle income countries—81.6%, P <
0.001 for Statement 1; 90.3% vs 75.0% vs 78.9%,
P = 0.009 for Statement 2; 90.7% vs 66.7% vs
86.8%, P < 0.001 for Statement 3; 85.3% vs 60.0%
vs 71.1%, P = 0.001 for Statement 4; 82.4% vs
68.6% vs 86.8%, P = 0.041 for Statement 5).
Similarly, the finding that respondents from the
United States and Canada have lower rates of
concern regarding the ethics of CIED reuse than
other respondents was still the case when exclud-
ing immigrant respondents (10.1% vs 30.8% vs
23.7%, P < 0.001).
Discussion
Major Findings
The main finding of this study is that a large
majority of HRS survey respondents support the
concept of postmortem pacemaker and ICD reuse
for patients in LMICs who cannot afford new
devices. This finding was consistent across the
spectrum of national incomes with strong support
in the United States/Canada, other high-income
countries, and lower- and upper-middle income
countries. There appears to be a widespread
belief among respondents that reimplantation of
resterilized CIEDs is safe, reasonable, and ethical.
While support for CIED reuse is higher in the
United States and Canada than in other high-
income countries, when taken together, HRS
members from these countries display an approval
rate similar to respondents from lower- and upper-
middle income countries.
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Interestingly, about a third of HRS physicians
surveyed reported having been asked about
postmortem device donation by their patients or
the patient’s family. This finding is consistentwith
the survey data by Gakenheimer et al., indicating
that 87% of patients with CIEDs and 71% of the
general population would support a pacemaker
reutilization initiative if given the opportunity.3
These data suggest that there is enough support
for donation among the patients and their families
that a large number of devices would potentially
be available, if legal and regulatory issues sur-
rounding CIED collection and reprocessing were
resolved.
Chief among these regulatory and legal
issues–detailed elsewhere by Kirkpatrick et al.5—
is current U.S. Food and Drug Administration
(FDA) policy, which designates pacemakers as
“single-use device” and considers pacemaker
reuse an “objectionable practice.”6 While this FDA
policy has not been revised since 1995,MyHeart—
Your Heart is currently engaged with the FDA to
obtain an investigational exemption detailing pro-
tocols for postmortem CIED acquisition, testing,
sterilization, and delivery, for the purposes of a
large clinical trial of CIED reuse. If these protocols
are proven to be safe and replicable by others,
they could potentially serve as a framework for
future changes to FDA policy. Although local laws
in recipient countries are also likely to influence
the practice of CIED reuse, many LMICs currently
have a less litigious climate than the United States
and other potential donor countries. Since CIEDs
are labeled as single-use, warranties do not cover
reuse, and manufacturers would be unlikely to
be held responsible in cases of reused device
malfunction.5
CIEDs reuse may also conflict with the
traditional practice of returning explanted devices
to the originalmanufacturer for analysis for quality
improvement testing. Postmortem property rights
pertaining to explantedmedical devices are not yet
well established and it is unclear which legal party
has jurisdiction to determine what is done with
an explanted CIED. Also, a theoretical concern
exists that international distribution of explanted
CIEDs could inadvertently result in the creation
of a “black market” for devices, particularly in
LMICs where resources for market regulation are
limited.7
In our study, the most prevailing concern
among HRS physician members regarding device
reuse was infection risk, which was reported
by 64% of respondents. Concern about device
malfunction was reported only by 29%. Despite
the inherent risk of transmitting infection from
the device donor to the recipient, a meta-analysis
including 18 cohort studies of pacemaker reuse
showed that the risk of infection was <2%, and
not statistically different from the infection risk
associatedwith implantation of new devices (odds
ratio 1.31 [0.50 to 3.40], P = 0.580).8 Standard-
ized sterilization protocols, similar to those for
hemodialysis filters or other reusable medical
equipment,5 are needed to ensure that sterilization
is effective across multiple donation sites. For
example, in one case series, debris was manually
removed from the device with pipe cleaners,
bathed in isopropyl alcohol, soaked overnight in
an enzymatic cleaner, wiped with 70% ethanol,
air dried, packed in gas-permeable envelopes, and
finally decontaminated via ethylene oxide gas
sterilization.9
The aforementioned meta-analysis also
showed that device malfunction was more likely
with reused devices (odds ratio 5.80 [1.93 to
17.47], P = 0.002), with malfunction occurring
in 0.68% of reimplanted devices—probably an
acceptable rate for a patient suffering from a
bradyarrhythmia whose alternative is no device
at all. Malfunctions were mostly attributed to
abnormalities in set screws which may have
occurred during extraction. This risk could be
reduced by adequate training of funeral directors
and close monitoring for device malfunction after
reimplantation.8
In terms of long-term outcomes, a French
study examining 151 patients who underwent
implantation of a resterilized pacemaker found
no differences in actuarial survival compared to
those who received a new device10; similarly, a
study from Sweden, where reused pacemakers
accounted for 5% of all implanted devices in
1996, showed no evidence of increased patient
risk associated with pacemaker reuse.11 Still,
the high degree of concern for infection among
HRS members in this survey highlights the need
for a robust prospective clinical trial to more
accurately quantify this risk before the practice
of device reuse can be expanded. Efforts to recruit
physicians to participate in reuse programs will
need to emphasize safety.
The finding that HRS members practicing in
high-income countries outside of theUnited States
and Canada are less likely than those from the
United States and Canada to presently support
device reuse may have important implications,
given that a significant fraction of potential donor
patients reside in wealthy nations outside of
North America.12 Even though nearly a third
(98, 31.0%) of respondents who practice in the
United States and Canada actually immigrated
to these countries, these trends persisted even
when excluding immigrants from the analysis. A
higher rate of ethical concerns among physicians
practicing in high-income countries excluding the
PACE, Vol. 37 August 2014 975
HUGHEY, ET AL.
United States and Canada may largely explain
this discrepancy. The reasons for the higher
rate of ethical concern outside of the United
States and Canada are not clear from these
data. Variations in ethical standards, cultural
beliefs, and level of trust in the reliability of
potential device reuse programs may account for
some of these differences. One respondent from
China cited a concern that “patients may not
believe [device reuse] is safe,” suggesting that
physicians’ anticipation of patients’ concerns may
also play a role in their receptiveness to device
reimplantation. Further study is needed to identify
the root causes of the differences in the degree of
ethical concerns, if efforts to involve physicians
from outside the United States and Canada in
device reuse programs are to be successful. The
ethical implications of CIED reuse—in particular,
whether it is ethical to transfer resterilized CIEDs
with possible higher risk of malfunction and
less battery life than a new device to LMICs—
have been discussed previously by Aragam et al.2
Our position is that implantation of resterilized
CIEDs is ethical because it is only offered to
patients who could not otherwise obtain a device
after informed consent, and it offers significant
mortality and quality-of-life benefit compared to
the alternative (no device). An analogous practice
already commonplace in the United States is
“expanded criteria donor” organ transplantation,
whereby organs at greater risk of failure are offered
to patients who otherwise may never receive an
organ. However, rigorous quality protocols are
needed to ensure that device reuse programs
approximate, as much as possible, the quality of
implant and follow-up care available in wealthy
countries.
Study Limitations
This study has several limitations. First, be-
cause all survey respondents were HRS members
and disproportionately from academic settings,
their opinions are not necessarily generalizable
to all electrophysiologists. However, subgroup
analysis did not show any statistically significant
differences in rates of agreement with positive
statements regarding CIED reuse between physi-
cians who practice in academic settings and those
in private practice. While the response rate of 13%
is low, it is typical for contemporary published
surveys of HRS members or electrophysiologists
(10%,13 10%,14 and 16%15). Future efforts to
reach more electrophysiologists could make use
of shorter surveys or monetary incentives to
improve response rates.16 Since completion of
the survey was voluntary, it is possible that HRS
members who responded to the survey were more
likely to already be familiar or interested in the
concept of device reuse, and therefore their views
regarding the practice may be more positive than
those of all HRS physician members. Despite
this possible bias, respondents to this survey
were geographically well representative of HRS
physician members, as 74% of all HRS physician
members practice in the United States and Canada
(74% in this survey), 17% practice in high-
income countries outside of the United States and
Canada (14% in this survey), and 9% practice in
lower-middle income countries and upper-middle
(8% in this survey).17 It should be noted that
even countries considered by the World Bank as
“upper-middle” and “lower-middle” income on a
per-capita basis, such as India,18 Mexico,19 and the
Philippines,9 are potential beneficiaries of CIED
reuse, and their views are captured in this survey.
However, physicians practicing in World Bank
“low-income” countries (i.e., per capita income
of $1,035 USD or less), such as Haiti and North
Korea, are not well represented in the HRS (0.03%
of physician members), and none completed this
survey. A separate survey specifically targeting
greater numbers of implanting physicians in recip-
ient countries should be performed to fully explore
their acceptance of reuse and identify barriers to
reuse. Finally, while this quantitative survey can
identify trends of opinion among HRS members,
it does not explore the rationale behind those
opinions. Qualitative research such as interviews
or focus groups would be better suited for this
purpose.
Conclusions
Pacemaker and ICD reuse has the poten-
tial to help many patients who are currently
denied these therapies due to prohibitive cost.
A large majority of HRS survey respondents
support the concept of pacemaker and ICD
reuse for patients in LMICs who cannot afford
new devices. Further work is needed to more
definitively demonstrate the clinical efficacy and
safety of this practice, and to identify poten-
tial barriers to adoption among physicians in
LMICs.
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